BioMarin to pay $4.8B for Amicus and its rare disease drugsnews2025-12-19T16:10:45+00:00December 19th, 2025|Endpoints News|
Senators point fingers over who blocked the rare disease voucher reauthorizationnews2025-12-19T15:43:21+00:00December 19th, 2025|Endpoints News|
Altimmune advances in MASH; New China obesity biotech; Ipsen Phase 2 failnews2025-12-19T15:41:31+00:00December 19th, 2025|Endpoints News|
European butadiene January 2026 contract price drops €20/tonnenews2025-12-19T14:00:00+00:00December 19th, 2025|Independent Commodity Intelligence Services (ICIS)|
Plant status: Spain’s Elix Polymers declares force majeure on ABS after firenews2025-12-19T13:55:00+00:00December 19th, 2025|Independent Commodity Intelligence Services (ICIS)|
INSIGHT: EU auto sector concessions fail to meet the momentnews2025-12-19T13:47:00+00:00December 19th, 2025|Independent Commodity Intelligence Services (ICIS)|
China acetic acid run rate rises on plant restartnews2025-12-19T13:21:00+00:00December 19th, 2025|Independent Commodity Intelligence Services (ICIS)|
Joe Jimenez’s Aditum goes to Fosun for major biobuck-loaded collaborationnews2025-12-19T13:15:31+00:00December 19th, 2025|Endpoints News|
